Merck Provides New Funding to Fight HIV/AIDS in Botswana | Bill & Melinda Gates Foundation
Merck company foundation supports successful HIV/AIDS initiative led by government
WHITEHOUSE STATION, N.J. -- Merck today announced the Merck Company Foundation and the Bill & Melinda Gates Foundation are committing an additional $60 million to support Botswana’s African Comprehensive HIV/AIDS Partnerships (ACHAP). Merck is known as MSD outside the US and Canada. A unique program developed with and led by the Government of Botswana, ACHAP is one of sub-Saharan Africa’s oldest, most successful public-private partnerships. With today’s pledge, the Merck Foundation and the Gates Foundation’s total cash contributions now amount to $166.5 million. Merck will also continue the donation of its HIV medicines.
To read the full press release, visit Merk's web site.